Dr. Salami is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd.
Dallas, TX 75390Phone+1 214-645-7700
Summary
- Aitua Salami, M.D., M.P.H. is a thoracic surgeon/assistant professor in the Department of Cardiovascular and Thoracic Surgery at UT Southwestern Medical Center. Dr. Salami's clinical focus is on minimally invasive and robotic thoracic surgery. He specializes in treating benign and malignant diseases of the lungs, pleura, esophagus, trachea, mediastinum, chest wall, and diaphragm.
Education & Training
- University of MinnesotaFellowship, Thoracic Surgery, 2021 - 2024
- Albert Einstein Healthcare NetworkResidency, Surgery, 2016 - 2021
- Mayo Clinic College of Medicine and Science (Rochester)Internship, Surgery, 2015 - 2016
- University of Benin Faculty of MedicineClass of 2009
Certifications & Licensure
- TX State Medical License 2024 - 2026
- MN State Medical License 2021 - 2025
- PA State Medical License 2016 - 2021
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Robotic Thoracic Surgery Equity and Access Award Thoracic Surgery Foundation, 2024
- Thoracic Surgical Robotics Fellowship American Association of Thoracic Surgery, 2024
- Coleman Connolly Award in Thoracic Surgery University of Minnesota, 2024
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsGeographic disparities in surgical treatment recommendation patterns and survival for pancreatic adenocarcinomaAitua Salami, Nkosi H. Alvarez, Amit R.T. Joshi
HPB. 2017-08-31 - 46 citationsEstablishment of a Regional Virtual Tumor Board Program to Improve the Process of Care for Patients With Hepatocellular Carcinoma.Aitua Salami, Gala M. Barden, Diana L. Castillo, Mina Hanna, Nancy J. Petersen
Journal of Oncology Practice. 2015-01-01 - 41 citationsPost-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma.Meredith C. Mason, Nader N. Massarweh, Aitua Salami, Mark A. Sultenfuss, Daniel A. Anaya
HPB. 2015-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: